AZD7594 is primarily investigated for its potential therapeutic applications in respiratory diseases, particularly asthma and chronic obstructive pulmonary disease (COPD). It functions as a non-steroidal, selective glucocorticoid receptor modulator, aiming to reduce inflammation in the airways without the systemic side effects often associated with traditional steroids. This makes it a promising candidate for long-term management of chronic respiratory conditions, improving patient outcomes by minimizing adverse effects. Additionally, its targeted action could enhance compliance and quality of life for individuals requiring prolonged anti-inflammatory treatment.